UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): February 1822, 2005 (February 17, 2005)

Advanced Neuromodulation Systems, Inc.

(Exact name of registrant as specified in ~~its~~ charter)


Texas	0-10521	75-1646002

(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

6901 Preston ~~Road~~Rd. Plano, Texas 75024 ~~(Address of principal executive offices) (Zip code)~~

(Address of principal executive offices) (Zip code)

Registrant’s telephone number, including area code:
(972) 309-8000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

TABLE OF CONTENTS

	Item 8.01 “Other Events”.
		Item 2.02. “Results of Operations and Financial Condition” and Item 7.01. Regulation FD Disclosure
SIGNATURES
INDEX TO EXHIBITS
Press Release
Press Release
Transcript of Conference Call

Item 82.0102. “~~Other~~Results ~~Events~~of Operations and Financial Condition” and Item 7.01. “Regulation FD Disclosure”

OnWe ~~February 14,~~are ~~15,~~furnishing ~~16 and 17, 2005, Advanced Neuromodulation Systems, Inc. (~~the ~~“Company”), through~~following ~~its~~under ~~wholly-owned~~this ~~subsidiary,~~Form SPAC Acquisition Corp., sold all of the 3.5 million shares of the common stock of Cyberonics, Inc. held by the Company. All 3.5 million shares were sold in open market transactions. The common stock of Cyberonics, Inc. had previously been acquired by the Company on August 12 and 13, 2004. Gross proceeds from the sale were approximately $135,290,000 and the Company expects to have a pre8-~~tax gain of approximately $85,200,000.~~K:

	•	a press release issued on February 17, 2005, disclosing information regarding our results of operations and financial condition for the fourth quarter and fiscal year of 2004, and our financial outlook for the fiscal year of 2005, a copy of which is attached hereto as Exhibit 99.1.

	•	the transcript of a conference call held on February 17, 2005 discussing our results of operations and financial condition for the fourth quarter and fiscal year of 2004, and our financial outlook for the fiscal year of 2005, a copy of which is attached hereto as Exhibit 99.2

~~SIGNATURES~~ Neither the press release nor the conference call transcript shall be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.

PursuantTable to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Contents

~~Dated: February 18, 2005~~SIGNATURES

~~ADVANCED~~ Pursuant ~~NEUROMODULATION~~to ~~SYSTEMS,~~the ~~INC.~~requirements ~~By:~~of ~~/s/~~the F.Securities ~~Robert~~Exchange ~~Merrill~~Act ~~III~~of ~~Name:~~1934, F.the ~~Robert~~Registrant ~~Merrill~~has ~~III~~duly caused ~~Title:~~this ~~Executive~~report ~~Vice~~to ~~President,~~be ~~Finance,~~signed ~~Chief~~on ~~Financial~~its ~~Officer~~behalf ~~and~~by ~~Treasurer~~the undersigned thereunto duly authorized.

~~Table~~ Dated: ofFebruary 22, ~~Contents~~2005

~~INDEX~~ADVANCED TONEUROMODULATION ~~EXHIBITS~~ SYSTEMS, INC. By: /s/ F. Robert Merrill III Name: F. Robert Merrill III Title: Executive Vice President, Finance, Chief Financial Officer and Treasurer

Exhibit
Number		Description
99.1		Press Release dated February 18, 2005 (This press release shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act)

INDEX TO EXHIBITS


Exhibit
Number		Description
99.1		Press Release dated February 17, 2005 (This press release shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act)

99.2		Transcript from conference call on February 17, 2005. (This transcript shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act)

Table of Contents

Table of Contents

Table of Contents

PursuantTable to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Contents

Table of Contents

Filing Compare · ADVANCED NEUROMODULATION SYSTEMS INC